Experiments for taxon Dracaena draco (AGAVACEAE)

Experiments (83 results)

Filters
Worktypes (13)
48
36
27
14
14
13
13
12
8
7
6
4
4
No match
Pharmacology (10)
14
10
2
2
1
1
1
1
1
50
No match
Compounds (57)
17
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
6
No match
Organisms (11)
30
13
11
8
8
3
3
2
2
2
1
No match
83 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
233810
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
SPIROST-5-EN-3-BETA-OL-3-O-[-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(R):
478849
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
478850
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
1055761
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
233804
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-24-TETROL-1-O-[0-(2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSYL]-24-O-BETA-D-FUCOPYRANOSIDE 23(S)-24(S):
309872
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DIOSGENIN-3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-4)-BETA-D-GLUCOPYRANOSIDE
1036184
ISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
HOMOISOFLAVAN,4'-5-DIHYDROXY:
1055758
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
233803
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-24-TETROL-1-O-[0-(2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSYL]-24-O-BETA-D-FUCOPYRANOSIDE 23(S)-24(S):
1302910
VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INDUCTION
Dracaena draco (AGAVACEAE)
ICOGENIN
478853
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIYEAST ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
309876
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DIOSCIN
1167399
MEDICINAL FOLKLORE REPORTED FOR
DYE-CONTAINING PLANT
Dracaena draco (AGAVACEAE)
233806
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-24-TETROL-1-O-[O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSIDE] 23(S)-24(S):
260941
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHALCONE,4-4'-DIHYDROXY-2'-METHOXY:CHROMAN,7-HYDROXY-3-(4-HYDROXY-BENZYL)-8-METHOXY:
580446
MEDICINAL FOLKLORE REPORTED FOR
HEMOSTATIC ACTIVITY
Dracaena draco (AGAVACEAE)
309879
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]:
260944
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
FLAVAN,4'-7-DIHYDROXY-3'-METHOXY: 2(S):
309868
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
DRACONIN B
260938
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHROMAN,3-(4-HYDROXY-BENZYL)-7-8-METHYLENEDIOXY:
478847
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
64691
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DIOSGENIN
260936
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHROMENE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):FLAVAN,4'-7-DIHYDROXY-3'-METHOXY-8-METHYL: 2(S):FLAVAN,4'-5-DIHYDROXY-7-METHOXY-8-METHYL: 2(S):FLAVAN,3'-7-DIHYDROXY-4'-METHOXY-8-METHYL: 2(S):
1055757
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DRACOGENIN
1055764
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
260945
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CINNAMYL ALCOHOL,3-4-5-TRIMETHOXY:
309871
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DRACONIN C
233809
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SPIROST-5-EN-3-BETA-OL-3-O-[-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE] 25(R):
1036183
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
FLAVONE,3-4'-DIHYDROXY-7-METHOXY:HOMOISOFLAVAN,4'-7-DIHYDROXY:FLAVAN,4'-7-DIHYDROXY-3'-METHOXY-8-METHYL: 2(S):FLAVAN,4'-5-DIHYDROXY-7-METHOXY-8-METHYL: 2(S):HOMOISOFLAVAN,4'-7-DIHYDROXY-8-METHOXY:HOMOISOFLAVONE,4'-5-7-TRIHYDROXY-6-METHYL:HOMOISOFLAVONE,4'-7-DIHYDROXY-6-METHYL:
309885
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
PROTODIOSCIN
309886
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CAROTEN-8'-AL,BETA-APO: TRANS:
478852
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
580445
MEDICINAL FOLKLORE REPORTED FOR
HEMOSTATIC ACTIVITY
Dracaena draco (AGAVACEAE)
309866
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
DRACONIN A
309882
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
GRACILLIN
309887
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SITOSTEROL,BETA:
233811
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-DIOL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]
309877
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DIOSCIN
309893
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CATECHOL,4-ALLYL:
309869
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DRACONIN B
309874
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]:
1055763
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
580447
MEDICINAL FOLKLORE REPORTED FOR
ANTICOAGULANT ACTIVITY
Dracaena draco (AGAVACEAE)
309892
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
FLAVAN,4'-7-DIHYDROXY-3'-METHOXY: 2(S):
309870
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
DRACONIN C
309881
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
TRIGOFOENOSIDE D-1
233808
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-TRIOL-1-O-[O-(4-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSIDE] 23(S):
309895
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SITOINDOSIDE I
260935
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
CHROMONE,7-HYDROXY-3-(4-HYDROXY-BENZYL):
309884
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
PROTODIOSCIN
64689
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
DRACOGENIN
260940
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHROMAN,7-HYDROXY-3-(4-HYDROXY-BENZYL):LIQUIRITIGENIN,ISO:
309867
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DRACONIN A
309888
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DIOSGENIN
1302909
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena draco (AGAVACEAE)
ICOGENIN
1216478
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Dracaena draco (AGAVACEAE)
309878
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]:
260934
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
CHROMAN-3-(4-HYDROXY-BENZYL)-5-7-DIMETHOXY:
260939
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DRACAENONE,10-HYDROXY-11-METHOXY:LIQUIRITIGENINCHROMAN-4-ONE,5-7-DIHYDROXY-3-(4-HYDROXY-BENZYL):
64690
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
RUSCOGENIN,NEO:
1055759
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
233812
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-TRIOL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE] 23(S):
260942
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
XENOGNOSINLOUREIRIN C
478851
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
309891
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
LOUREIRIN C
1055760
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
309883
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
GRACILLIN
260933
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
CHALCONE,DIHYDRO: 2-4-4'-TRIHYDROXY:
309880
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
TRIGOFOENOSIDE D-1
1055762
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
309873
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
DIOSGENIN-3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-4)-BETA-D-GLUCOPYRANOSIDE
309894
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
LIQUIRITIGENIN,ISO:
478848
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Dracaena draco (AGAVACEAE)
DRACOGENIN
478846
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
DRACOGENIN
233813
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-EPSILON-26-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]'2-6-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
1167400
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Dracaena draco (AGAVACEAE)
309875
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]:
233807
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
SPIROSTA-5-25(27)-DIENE-1-BETA-3-BETA-23-TRIOL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-ALPHA-L-ARABINOPYRANOSIDE] 23(S):
309890
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHROMANE,7-HYDROXY-3-(4-HYDROXY-BENZYL):
233805
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Dracaena draco (AGAVACEAE)
STIGMASTA-5-25(27)-DIENE-1-BETA-3-BETA-23-24-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE] 23(S)-24(S):
260943
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
CHROMAN-4-ONE,7-HYDROXY-3-(4-HYDROXY-BENZYL):
309889
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
FLAVAN,8-METHYL: 3'-7-DIHYDROXY-4'-METHOXY:
260937
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena draco (AGAVACEAE)
FLAVAN,4'-7-DIHYDROXY-8-METHYL: 2(S):